Class information for:
Level 1: IMMUNOCYTOKINES//IMMUNOCYTOKINE//PHILOCHEM AG

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
14311 712 41.8 86%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
701 12232 RADIOIMMUNOTHERAPY//BISPECIFIC ANTIBODIES//EP CAM

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 IMMUNOCYTOKINES Author keyword 21 73% 2% 16
2 IMMUNOCYTOKINE Author keyword 20 59% 3% 23
3 PHILOCHEM AG Address 17 63% 2% 17
4 CH1418 Author keyword 15 88% 1% 7
5 EXTRA DOMAIN B OF FIBRONECTIN Author keyword 11 78% 1% 7
6 ED B Author keyword 10 73% 1% 8
7 GD2 Author keyword 9 36% 3% 21
8 UNIT INNOVAT THER IES Address 9 83% 1% 5
9 3F8 Author keyword 9 67% 1% 8
10 APTIDES Author keyword 8 75% 1% 6

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 IMMUNOCYTOKINES 21 73% 2% 16 Search IMMUNOCYTOKINES Search IMMUNOCYTOKINES
2 IMMUNOCYTOKINE 20 59% 3% 23 Search IMMUNOCYTOKINE Search IMMUNOCYTOKINE
3 CH1418 15 88% 1% 7 Search CH1418 Search CH1418
4 EXTRA DOMAIN B OF FIBRONECTIN 11 78% 1% 7 Search EXTRA+DOMAIN+B+OF+FIBRONECTIN Search EXTRA+DOMAIN+B+OF+FIBRONECTIN
5 ED B 10 73% 1% 8 Search ED+B Search ED+B
6 GD2 9 36% 3% 21 Search GD2 Search GD2
7 3F8 9 67% 1% 8 Search 3F8 Search 3F8
8 APTIDES 8 75% 1% 6 Search APTIDES Search APTIDES
9 ARMED ANTIBODY 8 100% 1% 5 Search ARMED+ANTIBODY Search ARMED+ANTIBODY
10 EDB DOMAIN OF FIBRONECTIN 8 100% 1% 5 Search EDB+DOMAIN+OF+FIBRONECTIN Search EDB+DOMAIN+OF+FIBRONECTIN

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 ED B DOMAIN 60 62% 9% 62
2 ANTIGANGLIOSIDE GD2 ANTIBODY 57 79% 5% 37
3 TARGETED INTERLEUKIN 2 THERAPY 44 67% 6% 40
4 IMMUNOCYTOKINE 38 93% 2% 14
5 NEUROBLASTOMA METASTASES 38 86% 3% 19
6 FIBRONECTIN ISOFORM 38 64% 5% 37
7 HUMAN NEUROBLASTOMA METASTASES 30 100% 2% 12
8 CELL MEDIATED ERADICATION 26 87% 2% 13
9 IMMUNOCYTOKINE L19 IL2 26 87% 2% 13
10 COLON CARCINOMA METASTASES 22 81% 2% 13

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Armed antibodies for cancer treatment: a promising tool in a changing era 2015 2 53 38%
Disialoganglioside GD2 as a therapeutic target for human diseases 2015 1 119 42%
Immunocytokines: a novel class of potent armed antibodies 2012 35 87 69%
Antibody targeted drugs as cancer therapeutics 2006 337 104 22%
Engineering anti-GD2 monoclonal antibodies for cancer immunotherapy 2014 9 110 38%
Anti-GD2 Antibody Therapy for GD2-Expressing Tumors 2010 40 64 61%
Disialoganglioside directed immunotherapy of neuroblastoma 2007 42 88 51%
Fibronectin as target for tumor therapy 2006 99 81 41%
Tumour vascular targeting 2005 347 148 18%
From target discovery to clinical trials with armed antibody products 2014 1 46 80%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 PHILOCHEM AG 17 63% 2.4% 17
2 UNIT INNOVAT THER IES 9 83% 0.7% 5
3 HEART NORTH RHINE WESTPHALIA 1 38% 0.4% 3
4 HCI G396 1 100% 0.3% 2
5 INNOVAT THER IES 1 33% 0.4% 3
6 RECOMBINANT THER EUT PROT 1 40% 0.3% 2
7 ANTIANGIOGENESIS 1 50% 0.1% 1
8 CANC IMMUNOL BIOL 1 50% 0.1% 1
9 FED HOSP SALZBURG 1 50% 0.1% 1
10 IMMUNOL IMM13 1 50% 0.1% 1

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000120413 POLYVALENT ANTIGEN//AUTOLOGOUS ANTIBODY//B700
2 0.0000101002 EXTRA DOMAIN A CONTAINING FIBRONECTIN//FIBRONECTIN DOMAINS//RECOMBINANT FIBRONECTIN FRAGMENT
3 0.0000087416 ANTIBODY DRUG CONJUGATE//ANTIBODY DRUG CONJUGATES//T DM1
4 0.0000087129 NEUROBLASTOMA//MYCN//MYCN AMPLIFICATION
5 0.0000083178 SCFV//SINGLE CHAIN FV//PHAGE DISPLAY
6 0.0000082614 EGF DEXTRAN//ANTIBODY BINDING PARAMETERS//BIOMED RADIAT SCI
7 0.0000081573 BISPECIFIC ANTIBODIES//CATUMAXOMAB//TRIFUNCTIONAL ANTIBODY
8 0.0000080995 ADV CELL MOL THER Y//SHUNDE PEOPLES HOSP//TUMOR VACCINE
9 0.0000080362 MED CHILDRENS HOSP FDN//PEDIAT SURG 219 BRYANT ST//PESQUISA SOBRE TIMO
10 0.0000072233 EP CAM//TROP2//EDRECOLOMAB